Pfeffer K, Heeg K, Bubeck R, Conradt P, Wagner H
Curr Top Microbiol Immunol. 1989;152:211-7. doi: 10.1007/978-3-642-74974-2_25.
Two protocols were examined for the ability to transfer a human T cell system into SCID mice. Upon intraperitoneal injection (i.p.) of human peripheral blood lymphocytes (PBL) into SCID mice the injected cells could be recovered over weeks from the peritoneal cavity, yet human T cells did not seed into secondary lymphoid organs such as the spleen, lymph nodes or bone marrow. In contrast, SCID mice grafted with human embryonal thymus tissue contained high numbers of CD4+CD8- and CD8+CD4- human T cells in their lymph nodes and spleen when they had been injected i.p. with human PBL.
研究了两种将人类T细胞系统转移到重症联合免疫缺陷(SCID)小鼠体内的方案。将人类外周血淋巴细胞(PBL)腹腔注射(i.p.)到SCID小鼠体内后,注射的细胞在数周内可从腹腔中回收,但人类T细胞并未在脾脏、淋巴结或骨髓等二级淋巴器官中定植。相比之下,当腹腔注射人类PBL时,移植了人类胚胎胸腺组织的SCID小鼠的淋巴结和脾脏中含有大量CD4+CD8-和CD8+CD4-人类T细胞。